| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |